Autoliv, Inc. (ALV)

Marinus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 10 analysts that cover Marinus Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $122.1, which forecasts a 4.22% increase in the stock price over the next year. The lowest target is $100 and the highest is $140.

Price Target: $122.1 (+4.22%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$100	$122.1	$124	$140
Change	-14.65%	+4.22%	+5.84%	+19.49%

Analyst Ratings

The average analyst rating for Marinus Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	3	3	3	3	4	4
Buy	3	4	4	5	4	3
Hold	6	5	4	4	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	11	12	12	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luke Junk Baird	Baird	Hold Maintains $126 → $124	Hold	Maintains	$126 → $124	+5.84%	Jul 21, 2025
Dan Levy Barclays	Barclays	Buy Maintains $105 → $135	Buy	Maintains	$105 → $135	+15.23%	Jul 16, 2025
Luke Junk Baird	Baird	Hold Maintains $108 → $126	Hold	Maintains	$108 → $126	+7.55%	Jul 11, 2025
Vanessa Jeffriess Jefferies	Jefferies	Strong Buy Initiates $140	Strong Buy	Initiates	$140	+19.49%	Jul 2, 2025
Colin Langan Wells Fargo	Wells Fargo	Hold Maintains $100 → $104	Hold	Maintains	$100 → $104	-11.23%	Jul 1, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

10.78B

Increased by 3.73%

from 10.39B

Revenue Next Year

11.21B

Increased by 3.98%

from 10.78B

EPS This Year

8.92

Increased by 10.89%

from 8.04

EPS Next Year

10.60

Increased by 18.86%

from 8.92

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	7.45B	8.23B	8.84B	10.48B	10.39B	10.78B	11.21B	11.87B
Revenue Growth	-12.88%	10.51%	7.44%	18.47%	-0.81%	3.73%	3.98%	5.92%
EPS	2.14	4.96	4.85	5.72	8.04	8.92	10.60	12.61
EPS Growth	-59.55%	131.78%	-2.22%	17.94%	40.56%	10.89%	18.86%	19.00%
Forward PE	-	-	-	-	-	13.14	11.06	9.29
No. Analysts	-	-	-	-	-	20	21	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	11.4B	12.2B	13.2B
Avg	10.8B	11.2B	11.9B
Low	10.4B	10.4B	10.8B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	9.3%	13.1%	17.7%
Avg	3.7%	4.0%	5.9%
Low	-0.3%	-3.4%	-3.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	10.25	13.23	15.44
Avg	8.92	10.60	12.61
Low	7.67	8.99	10.13

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	27.5%	48.4%	45.7%
Avg	10.9%	18.9%	19.0%
Low	-4.6%	0.8%	-4.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.